E-LIB Suche - Ergebnisse für: Lichtenegger, Felix S

1

Blood DCs activated with R848 and poly(I:C) induce antigen-..:

Hänel, Gerulf ; Angerer, Caroline ; Petry, Katja..
Cancer Immunology, Immunotherapy. 71 (2021) 7 - p. 1705-1718 , 2021

2

Response to tyrosine kinase inhibitors in myeloid neoplasms..:

Schwaab, Juliana ; Naumann, Nicole ; Luebke, Johannes...
American Journal of Hematology. 95 (2020) 7 - p. 824-833 , 2020

Link: https://doi.org/10.1002/..

3

Toll‐like receptor 7/8‐matured RNA‐transduced dendritic cel..:

Lichtenegger, Felix S ; Schnorfeil, Frauke M ; Rothe, Maurine...
Clinical & Translational Immunology. 9 (2020) 3 - p. , 2020

Link: https://doi.org/10.1002/..

4

Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemi:

Van Acker, Heleen H. ; Versteven, Maarten ; Lichtenegger, Felix S....
Journal of Clinical Medicine. 8 (2019) 5 - p. 579 , 2019

Link: https://doi.org/10.3390/..

5

RIG-I-based immunotherapy enhances survival in preclinical ..:

Ruzicka, Michael ; Koenig, Lars M. ; Formisano, Simone...
Leukemia. 34 (2019) 4 - p. 1017-1026 , 2019

Link: https://doi.org/10.1038/..

6

Targeting LAG-3 and PD-1 to Enhance T Cell Activation by An..:

Lichtenegger, Felix S. ; Rothe, Maurine ; Schnorfeil, Frauke M....
Frontiers in Immunology. 9 (2018) - p. , 2018

Link: https://doi.org/10.3389/..

7

Recent developments in immunotherapy of acute myeloid leuke..:

Lichtenegger, Felix S. ; Krupka, Christina ; Haubner, Sascha..
Journal of Hematology & Oncology. 10 (2017) 1 - p. , 2017

Link: https://doi.org/10.1186/..

8

Targeting CD157 in AML using a novel, Fc-engineered antibod..:

Krupka, Christina ; Lichtenegger, Felix S. ; Köhnke, Thomas...
Oncotarget. 8 (2017) 22 - p. 35707-35717 , 2017

Link: https://doi.org/10.18632..

9

T cells are functionally not impaired in AML: increased PD-..:

Schnorfeil, Frauke M. ; Lichtenegger, Felix S. ; Emmerig, Katharina...
Journal of Hematology & Oncology. 8 (2015) 1 - p. , 2015

Link: https://doi.org/10.1186/..

10

RNA and protein expression of herpesvirus entry mediator (H..:

Lichtenegger, Felix S. ; Kondla, Isabell ; Krempasky, Michael...
Cancer Immunology, Immunotherapy. 64 (2015) 12 - p. 1505-1515 , 2015

Link: https://doi.org/10.1007/..

11

Impaired NK cells and increased T regulatory cell numbers d..:

Lichtenegger, Felix S. ; Lorenz, Robin ; Gellhaus, Katharina...
Leukemia Research. 38 (2014) 8 - p. 964-969 , 2014

Link: https://doi.org/10.1016/..

12

New generation dendritic cell vaccine for immunotherapy of ..:

Subklewe, Marion ; Geiger, Christiane ; Lichtenegger, Felix S....
Cancer Immunology, Immunotherapy. 63 (2014) 10 - p. 1093-1103 , 2014

Link: https://doi.org/10.1007/..

13

CD86 and IL-12p70 Are Key Players for T Helper 1 Polarizati..:

Lichtenegger, Felix S. ; Mueller, Katharina ; Otte, Bettina...
PLoS ONE. 7 (2012) 9 - p. e44266 , 2012

Link: https://doi.org/10.1371/..

14

Effects of TLR agonists on maturation and function of 3-day..:

Beck, Barbara ; Dörfel, Daniela ; Lichtenegger, Felix S...
Journal of Translational Medicine. 9 (2011) 1 - p. , 2011

Link: https://doi.org/10.1186/..

15

MBP-PLP fusion protein-induced EAE in C57BL/6 mice:

Kuerten, Stefanie ; Lichtenegger, Felix S. ; Faas, Susan...
Journal of Neuroimmunology. 177 (2006) 1-2 - p. 99-111 , 2006

Link: https://doi.org/10.1016/..